Name one company taking a fully personalized GBM treatment and platform for all other solid tumors into commercialization for worldwide SOC in GBM that hasn’t taken this long for TLD ; ). Best wishes.
I can give a couple of reasons. How well they show the data will determine pricing and they have to do this work anyway for approval. 2nd reason is how well the data is presented may reflect on how much easier it will be to get testing and approval on other indications.